Pharmacokinetics and pharmacodynamics

Pharmacokinetic activity depends on the amount of drug levels at the target site . Recent advances in analytical and quantitative methodologies are often non-invasive assessments of drug pharmacokinetics at the site of action for better understanding of pharmacokinetic properties.

Pharmacodynamics is affected by various factors including receptor binding and sensitivity, post receptor effects, chemical interactions,  physiologic changes due to genetic mutations, diseases, aging, or impact of other drugs. Pharmacodynamics and pharmacokinetics explain the effects of drugs to the host body. 

• Drug disposition
• Applied Pharmaceuticals
• Causality Evaluation
• In-vivo and In-vitro studies
• Stability tests

Pharmaceutics Conferences  inviting workshop proposals which covers ADME using nanomedicine, Drug permeability, Biodistribution of nanodrugs, Bioavailabity.

Clinical Pharmacy Conferences  welcoming short course proposals on Drug discovery.

Market Statistics:

The global pharmacokinetics services market size is expected to reach USD 1.2 billion by 2025, registering an 8.3% CAGR during the forecast period. Rising adoption of pharmacokinetic and toxicology studies for determination of several parameters such as no-observed-effect levels (NOEL), human equivalent doses (HED) levels, and pharmacokinetic/pharmacodynamic (PK/PD) drivers are expected to fuel market growth.